GMA-106 is under development for the treatment of type 2 diabetes, obesity and non-alcoholic steatohepatitis (NASH). The drug candidate is being developed based on Bibody platform. It acts by ...

Starting 2025 with a “new year, new me” mindset? Dairy is here to help you crush your top goals—check out these 25 reasons ...

Researchers at the University of Chicago have successfully captured detailed images of adhesion G protein-coupled receptors, ...

New research from the University of Chicago combines two powerful imaging techniques to study the complete structure of a ...

Boost your protein intake with beans, a nutritious and affordable option, by exploring the top high-protein varieties.